-- Israel Stocks: Clal Biotechnology, Partner, Sunflower, Tower
-- B y   S h o s h a n n a   S o l o m o n
-- 2012-02-13T15:49:37Z
-- http://www.bloomberg.com/news/2012-02-13/israel-stocks-clal-biotechnology-partner-sunflower-tower.html
Israel ’s  TA-25 index  declined for
the first time since Feb. 6, retreating 0.1 percent to 1,119.49
at the 4:30 p.m. close in Tel Aviv. Investors traded about 1.1
billion shekels ($295 million) of shares and convertible
securities, according to bourse data.  The following stocks rose or fell today. Symbols are in
parentheses.  Clal Biotechnology Industries Ltd. (CBI)   advanced the
most since Jan. 29, climbing 1.1 percent to 15.95 shekels. The
investor in biotechnology companies said its 20 percent-owned
Gamida Cell unit completed enrollment of patients for a Phase
III clinical trial for StemEx, a cord-blood stemcell product for
leukemia and lymphoma.  Koor Industries Ltd. (KOR)   soared 9.2 percent to 52.40
shekels, the highest since Aug. 3. Koor agreed to enter talks
for  Discount Investment Corp. (DISI)   to buy the rest of the
holding company for cash. Discount Investment, which owns 62.67
percent of Koor, according to Bloomberg data, slipped 0.1
percent to 24.83 shekels.  Partner Communications Co. (PTNR)   gained 2.2 percent to
32.73 shekels, the highest close since Jan. 23. UBS AG said
speculation of a minority buyout or a stake sale in Israel’s
second-largest mobile-telephone company may help shares in the
near term.  Sunflower Sustainable Investments Ltd. (SNFL)   advanced 3
percent to 8 shekels, the highest level since Nov. 30. The
developer of photo-voltaic solar-energy projects said a unit
will buy solar parks in Spain for 7.5 million euros ($9.9
million).  Tower Semiconductor Ltd. (TSEM)   surged to the highest
level in more than six months, jumping 6.7 percent to 3.22
shekels. The maker of customized chips said its Japanese unit
has been chosen to get a grant from Japan’s Ministry of Economy,
Trade and Industry.  WideMed Ltd. (WDMD)   increased 1.9 percent to 0.423
shekel, the highest since Jan. 23. The provider of bio-medical
signal diagnostics and treatments said it got an order for a
system from a U.S. hospital.  To contact the reporter on this story:
Shoshanna Solomon in Tel Aviv at 
 ssolomon22@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  